vimarsana.com

Page 2 - நுஃபையீல்ட் சபை ஆன் உயிர்வேதியியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Changing the Human Genome: What Next for Germline Genome Editing?

Changing the Human Genome: What Next for Germline Genome Editing?
bionews.org.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bionews.org.uk Daily Mail and Mail on Sunday newspapers.

New implementation plan to deliver world-leading genomic healthcare

19 May 2021 Government launches implementation plan to deliver world-leading genomic healthcare to patients, improving diagnosis, treatment and prevention Diversity and reach of genomics set to expand through engagement and research programmes to better treat deadly diseases such as cancer Patients across the UK will benefit from better healthcare, treatments and faster diagnosis as the government sets out how it will continue to deliver world-leading genomic healthcare. Genomics is the study of genetic information and can help diagnose diseases earlier and more accurately, reduce some invasive procedures and enable tailored treatments. Building on the success of the 100,000 Genomes Project, our commitment is to sequence 1 million whole genomes – 500,000 genomes in the NHS and 500,000 in UK Biobank, which will transform healthcare in the UK and create jobs. In 2018 to 2019, genomics contributed £1.9 billion to our economy.

Like taxes, equity aspect of vaccines is compelling

When much of the world is still desperate for COVID-19 vaccinations, a handful of wealthy places are beginning to have the opposite problem. Hong Kong is one. Despite a free and easily accessible programme open to all adults since April, only just over 10% of the

OP-ED: What happens when vaccine incentives aren t enough?

OP-ED: What happens when vaccine incentives aren’t enough? Clara Ferreira Marques Bloomberg Opinion (TNS) When much of the world is still desperate for COVID-19 vaccinations, a handful of wealthy places are beginning to have the opposite problem. Hong Kong is one. Despite a free and easily accessible program open to all adults since April, only just over 10% of the population of 7.5 million has had both injections, with low rates even among the oldest. Hesitancy is so high that only half of residents say they intend to get vaccinated. The combination of political upheaval, distrust in government and success in keeping caseloads low makes Hong Kong an unusual, even extreme, example of reluctance, as seen in studies of attitudes to other control measures, compared to Singapore and Malaysia. But the territory is far from alone as the rich world shifts from shortages to indifference, well before enough people have been inoculated to allow a safe reopening.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.